Skip to main content
Top
Published in: Journal of Cancer Survivorship 2/2010

01-06-2010

Views of primary care physicians and oncologists on cancer follow-up initiatives in primary care: an online survey

Authors: Eila K. Watson, Elaine M. Sugden, Peter W. Rose

Published in: Journal of Cancer Survivorship | Issue 2/2010

Login to get access

Abstract

Introduction

Primary care physicians (PCPs) are playing an increasing role in the follow-up of cancer in England. In 2003 a Cancer Care Review (CCR) was introduced to ensure contact between PCPs and cancer patients within 6 months of diagnosis. The NHS also intends to introduce survivorship care plans (SCP). The aims of this study were to: describe current practice and views in primary care with respect to the CCR and information provision from secondary to primary care following final discharge from hospital follow-up; and to seek views on the perceived usefulness, content, and feasibility of a SCP.

Methods

An on-line questionnaire survey of 100 oncologists and 200 PCPs.

Results

Half of PCPs undertook the CCR opportunistically, and only 64% had an agreed structure. Forty percent felt the CCR was useful for the doctor, and 60% useful for the patient. Most PCPs and oncologists think a SCP would be useful, but only 40% oncologists thought that it would be easy to produce. At discharge from follow-up, more than half of oncologists said they provided information on histology, treatment, requirements for screening and surveillance, and referral guidance. Less than half provide information on potential late effects and symptoms of recurrence. PCPs felt that information on all of these areas was important and that the information they receive is often inadequate.

Discussion/Conclusions

The CCR has not been implemented systematically. There is support for the introduction of a SCP and broad agreement on content. However, careful planning is needed to ensure all necessary information is included and to overcome barriers of implementation.

Implications for cancer survivors

Further research should explore what cancer survivors would find useful in a primary care-based CCR and what should be included in a SCP. This should be clearly communicated to the relevant health care professionals to maximise the benefits cancer survivors and their families gain from these policy initiatives.
Literature
1.
go back to reference Lewis RA, Neal RD, Williams NH, France B, Hendry M, Russell D, et al. Follow-up of cancer in primary care versus secondary care: systematic review. BJGP. 2009;59:243–7. Lewis RA, Neal RD, Williams NH, France B, Hendry M, Russell D, et al. Follow-up of cancer in primary care versus secondary care: systematic review. BJGP. 2009;59:243–7.
2.
go back to reference Beaver K, Tysver-Robinson D, Campbell M, Twomey M, Williamson S, Hindley A, et al. Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial. BMJ. 2009;338:a3147. doi:10.1136/bmj.a3147.CrossRefPubMed Beaver K, Tysver-Robinson D, Campbell M, Twomey M, Williamson S, Hindley A, et al. Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial. BMJ. 2009;338:a3147. doi:10.​1136/​bmj.​a3147.CrossRefPubMed
3.
go back to reference National Institute for Health and Clinical Excellence. Early and locally advanced breast cancer: diagnosis and treatment. Cardiff National Collaborating Centre for Cancer. 2009. National Institute for Health and Clinical Excellence. Early and locally advanced breast cancer: diagnosis and treatment. Cardiff National Collaborating Centre for Cancer. 2009.
4.
go back to reference National Institute for Health and Clinical Excellence. Prostate cancer diagnosis and treatment. Cardiff: National Collaborating Centre for Cancer, 2008. National Institute for Health and Clinical Excellence. Prostate cancer diagnosis and treatment. Cardiff: National Collaborating Centre for Cancer, 2008.
5.
go back to reference Lewis RA, Neal RD, Hendry M, France B, Williams NH, Russell D, et al. Patients’ and health care professionals’ views of cancer follow up: a systematic review. BJGP. 2009;59:248–59.CrossRef Lewis RA, Neal RD, Hendry M, France B, Williams NH, Russell D, et al. Patients’ and health care professionals’ views of cancer follow up: a systematic review. BJGP. 2009;59:248–59.CrossRef
6.
go back to reference O’Brien R, Rose P, Campbell C, Weller D, McIntosh H, Neal RD, et al. on behalf of the Prostate Cancer Follow-up Group. “I wish I’d told them”: a qualitative study examining the unmet psychosocial needs of prostate cancer patients and their partners after treatment. Manuscript submitted for publication. O’Brien R, Rose P, Campbell C, Weller D, McIntosh H, Neal RD, et al. on behalf of the Prostate Cancer Follow-up Group. “I wish I’d told them”: a qualitative study examining the unmet psychosocial needs of prostate cancer patients and their partners after treatment. Manuscript submitted for publication.
11.
go back to reference Hewitt M, Greenfield S, Stovall E (eds) From Cancer patient to cancer survivor: lost in transition. Washington, DC, Committee on Cancer Survivorship, Improving Care and Quality of Life, NationalCancer Policy Board, Institute of Medicine, and National Research Council, National Academies Press, 2006. Hewitt M, Greenfield S, Stovall E (eds) From Cancer patient to cancer survivor: lost in transition. Washington, DC, Committee on Cancer Survivorship, Improving Care and Quality of Life, NationalCancer Policy Board, Institute of Medicine, and National Research Council, National Academies Press, 2006.
13.
go back to reference NHS Workforce Review Team, unpublished data. NHS Workforce Review Team, unpublished data.
14.
15.
16.
go back to reference Baravelli C, Krishnasamy M, Pezaro C, Schofield P, Lofti-Jam K, Rogers M, Milne D, Aranda S, King D, Shaw B, Grogan S, Jefford M. The views of bowel cancer survivors and health care professionals regarding survivorship care plans and post treatment follow up. Journal of Cancer Survivorship. 2009. doi:10.1007/s11764-009-0086-1. Baravelli C, Krishnasamy M, Pezaro C, Schofield P, Lofti-Jam K, Rogers M, Milne D, Aranda S, King D, Shaw B, Grogan S, Jefford M. The views of bowel cancer survivors and health care professionals regarding survivorship care plans and post treatment follow up. Journal of Cancer Survivorship. 2009. doi:10.​1007/​s11764-009-0086-1.
17.
go back to reference Hewitt ME, Bamundo A, Day R, Harvey C. Perspectives on post-treatment cancer care: qualitative research with survivors, nurses and physicians. J Clin Oncol. 2007;25(16):2270–3.CrossRefPubMed Hewitt ME, Bamundo A, Day R, Harvey C. Perspectives on post-treatment cancer care: qualitative research with survivors, nurses and physicians. J Clin Oncol. 2007;25(16):2270–3.CrossRefPubMed
18.
go back to reference Johansson B, Berglund G, Hoffman K, Glimelius B, Sjoden P-O. The role of the general practitioner in cancer care and the effect of an extended information role. Scand J Prim Health Care. 2008;18:143–8. Johansson B, Berglund G, Hoffman K, Glimelius B, Sjoden P-O. The role of the general practitioner in cancer care and the effect of an extended information role. Scand J Prim Health Care. 2008;18:143–8.
19.
go back to reference Jefford M, Baravelli C, Dudgeon P, Dabscheck A, Evans M, Moloney M, et al. Tailored chemotherapy information faxed to general practitioners improves confidence in managing adverse effects and satisfaction with shared care: results from a randomized controlled trial. J Clin Oncol. 2008. doi:10.1200/JCO.2007.14.7710. Jefford M, Baravelli C, Dudgeon P, Dabscheck A, Evans M, Moloney M, et al. Tailored chemotherapy information faxed to general practitioners improves confidence in managing adverse effects and satisfaction with shared care: results from a randomized controlled trial. J Clin Oncol. 2008. doi:10.​1200/​JCO.​2007.​14.​7710.
Metadata
Title
Views of primary care physicians and oncologists on cancer follow-up initiatives in primary care: an online survey
Authors
Eila K. Watson
Elaine M. Sugden
Peter W. Rose
Publication date
01-06-2010
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 2/2010
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-010-0117-y

Other articles of this Issue 2/2010

Journal of Cancer Survivorship 2/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine